{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:40:43Z","timestamp":1769283643278,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10067-019-04886-7","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T08:05:16Z","timestamp":1576829116000},"page":"1357-1362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A patient with primary Sjogren\u2019s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6172-9474","authenticated-orcid":false,"given":"Leanna M.","family":"Wise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G.","family":"Arkfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"issue":"9482","key":"4886_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI (2005) Sj\u00f6gren\u2019s syndrome. Lancet 366(9482):321\u2013331. https:\/\/doi.org\/10.1016\/S0140-6736(05)66990-5","journal-title":"Lancet"},{"issue":"4","key":"4886_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J, Calvo-Alen J, Jim\u00e9nez-Alonso J, Mic\u00f3 ML, Beltr\u00e1n J, Belenguer R, Pallar\u00e9s L, GEMESS Study Group (2008) Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 87(4):210\u2013219. https:\/\/doi.org\/10.1097\/MD.0b013e318181e6af","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"4886_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","volume":"45","author":"Y Alamanos","year":"2006","unstructured":"Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA (2006) Epidemiology of primary Sjogren\u2019s syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 45(2):187\u2013191. https:\/\/doi.org\/10.1093\/rheumatology\/kei107","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"4886_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2014.931457","volume":"44","author":"M Kvarnstrom","year":"2015","unstructured":"Kvarnstrom M, Ottosson V, Nordmark B, Wahren-Herlenius M (2015) Incident cases of primary Sjogren\u2019s syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics. Scand J Rheumatol 44(2):135\u2013142. https:\/\/doi.org\/10.3109\/03009742.2014.931457","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"4886_CR5","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/acr.23173","volume":"69","author":"G Maciel","year":"2017","unstructured":"Maciel G, Crowson CS, Matteson EL, Cornec D (2017) Prevalence of primary Sjogren\u2019s syndrome in a US population-based cohort. Arthritis Care Res (Hoboken) 69(10):1612\u20131616. https:\/\/doi.org\/10.1002\/acr.23173","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"4886_CR6","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R (2015) Epidemiology of primary Sjogren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1983\u20131989. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205375","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4886_CR7","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","volume":"130","author":"JG Parambil","year":"2006","unstructured":"Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH (2006) Interstitial lung disease in primary Sjogren syndrome. Chest 130(5):1489\u20131495. https:\/\/doi.org\/10.1378\/chest.130.5.1489","journal-title":"Chest"},{"issue":"1","key":"4886_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","volume":"16","author":"F Roca","year":"2017","unstructured":"Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, L\u00e9vesque H, Marie I (2017) Interstitial lung disease in primary Sjogren\u2019s syndrome. Autoimmun Rev 16(1):48\u201354. https:\/\/doi.org\/10.1016\/j.autrev.2016.09.017","journal-title":"Autoimmun Rev"},{"issue":"6","key":"4886_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","volume":"171","author":"I Ito","year":"2005","unstructured":"Ito I, Nagai S, Kitaichi M et al (2005) Pulmonary manifestations of primary Sjogren\u2019s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171(6):632\u2013638. https:\/\/doi.org\/10.1164\/rccm.200403-417OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4886_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.anndiagpath.2012.03.005","volume":"17","author":"J Jagirdar","year":"2013","unstructured":"Jagirdar J, Chikkamuniyappa S, Sirohi D, McCarthy MJ, Peters JI (2013) Cystic lung lesions in Sjogren syndrome: analysis of lymphocyte subsets in tissue with clinico-radiologic-pathologic correlation. Ann Diagn Pathol 17(1):113\u2013116. https:\/\/doi.org\/10.1016\/j.anndiagpath.2012.03.005","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"4886_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.chest.2016.05.015","volume":"150","author":"CD Mart\u00ednez-Balzano","year":"2016","unstructured":"Mart\u00ednez-Balzano CD, Touray S, Kopec S (2016) Cystic lung disease among patients with Sj\u00f6gren syndrome: frequency, natural history, and associated risk factors. Chest 150(3):631\u2013639. https:\/\/doi.org\/10.1016\/j.chest.2016.05.015","journal-title":"Chest"},{"issue":"3","key":"4886_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccm.2016.04.009","volume":"37","author":"TS Panchabhai","year":"2016","unstructured":"Panchabhai TS, Farver C, Highland KB (2016) Lymphocytic interstitial pneumonia. Clin Chest Med 37(3):463\u2013474. https:\/\/doi.org\/10.1016\/j.ccm.2016.04.009","journal-title":"Clin Chest Med"},{"issue":"3","key":"4886_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1055\/s-0036-1580690","volume":"37","author":"KF Xu","year":"2016","unstructured":"Xu KF, Feng R, Cui H et al (2016) Diffuse cystic lung diseases: diagnostic considerations. Semin Respir Crit Care Med 37(3):457\u2013467. https:\/\/doi.org\/10.1055\/s-0036-1580690","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"4886_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","volume":"14","author":"A Papageorgiou","year":"2015","unstructured":"Papageorgiou A, Voulgarelis M, Tzioufas AG (2015) Clinical picture, outcome and predictive factors of lymphoma in Sjgren syndrome. Autoimmun Rev 14(7):641\u2013649. https:\/\/doi.org\/10.1016\/j.autrev.2015.03.004","journal-title":"Autoimmun Rev"},{"key":"4886_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fmed.2018.00102","volume":"5","author":"A Alunno","year":"2018","unstructured":"Alunno A, Leone MC, Giacomelli R, Gerli R, Carubbi F (2018) Lymphoma and lymphomagenesis in primary Sjogren\u2019s syndrome. Front Med (Lausanne) 5:102. https:\/\/doi.org\/10.3389\/fmed.2018.00102","journal-title":"Front Med (Lausanne)"},{"issue":"25","key":"4886_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000003766","volume":"95","author":"S Fragkioudaki","year":"2016","unstructured":"Fragkioudaki S, Mavragani CP, Moutsopoulos HM (2016) Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use. Medicine (Baltimore) 95(25):e3766. https:\/\/doi.org\/10.1097\/md.0000000000003766","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"4886_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"JP Ioannidis","year":"2002","unstructured":"Ioannidis JP, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren\u2019s syndrome. Arthritis Rheum 46(3):741\u2013747. https:\/\/doi.org\/10.1002\/art.10221","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4886_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.beha.2017.11.001","volume":"31","author":"I Defrancesco","year":"2018","unstructured":"Defrancesco I, Arcaini L (2018) Overview on the management of non-gastric MALT lymphomas. Best Pract Res Clin Haematol 31(1):57\u201364. https:\/\/doi.org\/10.1016\/j.beha.2017.11.001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"4886_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00002281-199709000-00004","volume":"9","author":"RI Fox","year":"1997","unstructured":"Fox RI, Maruyama T (1997) Pathogenesis and treatment of Sjogren\u2019s syndrome. Curr Opin Rheumatol 9(5):393\u2013399","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"4886_CR20","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1073\/pnas.0510837103","volume":"103","author":"JE Gottenberg","year":"2006","unstructured":"Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, Labetoulle M, Ardizzone M, Sibilia J, Fournier C, Chiocchia G, Mariette X (2006) Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren\u2019s syndrome. Proc Natl Acad Sci U S A 103(8):2770\u20132775. https:\/\/doi.org\/10.1073\/pnas.0510837103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4886_CR21","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ng.2779","volume":"45","author":"Y Li","year":"2013","unstructured":"Li Y, Zhang K, Chen H et al (2013) A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren\u2019s syndrome at 7q11.23. Nat Genet 45(11):1361\u20131365. https:\/\/doi.org\/10.1038\/ng.2779","journal-title":"Nat Genet"},{"key":"4886_CR22","doi-asserted-by":"publisher","unstructured":"Mingueneau M, Boudaoud S, Haskett S et al (2016) Cytometry by time-of-flight immunophenotyping identifies a blood Sjogren\u2019s signature correlating with disease activity and glandular inflammation. J allergy Clin Immunol 137 (6):1809-1821.e1812. doi:https:\/\/doi.org\/10.1016\/j.jaci.2016.01.024","DOI":"10.1016\/j.jaci.2016.01.024"},{"issue":"9","key":"4886_CR23","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","volume":"9","author":"G Nocturne","year":"2013","unstructured":"Nocturne G, Mariette X (2013) Advances in understanding the pathogenesis of primary Sjogren\u2019s syndrome. Nat Rev Rheumatol 9(9):544\u2013556. https:\/\/doi.org\/10.1038\/nrrheum.2013.110","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"4886_CR24","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1136\/annrheumdis-2016-210788","volume":"76","author":"S Tasaki","year":"2017","unstructured":"Tasaki S, Suzuki K, Nishikawa A, Kassai Y, Takiguchi M, Kurisu R, Okuzono Y, Miyazaki T, Takeshita M, Yoshimoto K, Yasuoka H, Yamaoka K, Ikeura K, Tsunoda K, Morita R, Yoshimura A, Toyoshiba H, Takeuchi T (2017) Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren\u2019s syndrome. Ann Rheum Dis 76(8):1458\u20131466. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210788","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4886_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1600-0714.2008.00700.x","volume":"38","author":"US Deshmukh","year":"2009","unstructured":"Deshmukh US, Nandula SR, Thimmalapura PR, Scindia YM, Bagavant H (2009) Activation of innate immune responses through toll-like receptor 3 causes a rapid loss of salivary gland function. J Oral Pathol Med 38(1):42\u201347. https:\/\/doi.org\/10.1111\/j.1600-0714.2008.00700.x","journal-title":"J Oral Pathol Med"},{"issue":"8","key":"4886_CR26","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.4049\/jimmunol.1000466","volume":"186","author":"N Jacob","year":"2011","unstructured":"Jacob N, Guo S, Mathian A, Koss MN, Gindea S, Putterman C, Jacob CO, Stohl W (2011) B cell and BAFF dependence of IFN-alpha-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. J Immunol 186(8):4984\u20134993. https:\/\/doi.org\/10.4049\/jimmunol.1000466","journal-title":"J Immunol"},{"issue":"4","key":"4886_CR27","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/art.22458","volume":"56","author":"C Daridon","year":"2007","unstructured":"Daridon C, Devauchelle V, Hutin P, le Berre R, Martins-Carvalho C, Bendaoud B, Dueymes M, Saraux A, Youinou P, Pers JO (2007) Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren\u2019s syndrome. Arthritis Rheum 56(4):1134\u20131144. https:\/\/doi.org\/10.1002\/art.22458","journal-title":"Arthritis Rheum"},{"issue":"11","key":"4886_CR28","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","volume":"190","author":"F Mackay","year":"1999","unstructured":"Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190(11):1697\u20131710. https:\/\/doi.org\/10.1084\/jem.190.11.1697","journal-title":"J Exp Med"},{"issue":"2","key":"4886_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/ard.62.2.168","volume":"62","author":"X Mariette","year":"2003","unstructured":"Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R (2003) The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren\u2019s syndrome. Ann Rheum Dis 62(2):168\u2013171. https:\/\/doi.org\/10.1136\/ard.62.2.168","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4886_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1046\/j.1365-3083.1999.00533.x","volume":"49","author":"A Halse","year":"1999","unstructured":"Halse A, Tengner P, Wahren-Herlenius M, Haga H, Jonsson R (1999) Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjogren\u2019s syndrome. Scand J Immunol 49(5):533\u2013538. https:\/\/doi.org\/10.1046\/j.1365-3083.1999.00533.x","journal-title":"Scand J Immunol"},{"issue":"4","key":"4886_CR31","first-page":"935","volume":"27","author":"S Perrier","year":"2000","unstructured":"Perrier S, Serre AF, Dubost JJ, Beaujon G, Plazonnet MP, Albuisson E, Sauvezie B (2000) Increased serum levels of interleukin 10 in Sjogren\u2019s syndrome; correlation with increased IgG1. J Rheumatol 27(4):935\u2013939","journal-title":"J Rheumatol"},{"issue":"3","key":"4886_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.clim.2008.10.006","volume":"130","author":"L Shen","year":"2009","unstructured":"Shen L, Suresh L, Li H, Zhang C, Kumar V, Pankewycz O, Ambrus JL Jr (2009) IL-14 alpha, the nexus for primary Sjogren\u2019s disease in mice and humans. Clin Immunol 130(3):304\u2013312. https:\/\/doi.org\/10.1016\/j.clim.2008.10.006","journal-title":"Clin Immunol"},{"issue":"4","key":"4886_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/00005382-200110000-00009","volume":"16","author":"M Uffmann","year":"2001","unstructured":"Uffmann M, Kiener HP, Bankier AA et al (2001) Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging 16(4):282\u2013289","journal-title":"J Thorac Imaging"},{"issue":"2","key":"4886_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejrad.2004.01.006","volume":"52","author":"C Lohrmann","year":"2004","unstructured":"Lohrmann C, Uhl M, Warnatz K, Ghanem N, Kotter E, Schaefer O, Langer M (2004) High-resolution CT imaging of the lung for patients with primary Sjogren\u2019s syndrome. Eur J Radiol 52(2):137\u2013143. https:\/\/doi.org\/10.1016\/j.ejrad.2004.01.006","journal-title":"Eur J Radiol"},{"issue":"2","key":"4886_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3899\/jrheum.090507","volume":"37","author":"M Watanabe","year":"2010","unstructured":"Watanabe M, Naniwa T, Hara M, Arakawa T, Maeda T (2010) Pulmonary manifestations in Sjogren\u2019s syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol 37(2):365\u2013373. https:\/\/doi.org\/10.3899\/jrheum.090507","journal-title":"J Rheumatol"},{"issue":"4","key":"4886_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/00005382-200110000-00010","volume":"16","author":"M Koyama","year":"2001","unstructured":"Koyama M, Johkoh T, Honda O, Mihara N, Kozuka T, Tomiyama N, Hamada S, Nakamura H (2001) Pulmonary involvement in primary Sjogren\u2019s syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging 16(4):290\u2013296","journal-title":"J Thorac Imaging"},{"issue":"912","key":"4886_CR37","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1259\/bjr\/18937619","volume":"76","author":"N Matsuyama","year":"2003","unstructured":"Matsuyama N, Ashizawa K, Okimoto T, Kadota J, Amano H, Hayashi K (2003) Pulmonary lesions associated with Sjogren\u2019s syndrome: radiographic and CT findings. Br J Radiol 76(912):880\u2013884. https:\/\/doi.org\/10.1259\/bjr\/18937619","journal-title":"Br J Radiol"},{"issue":"3","key":"4886_CR38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2214\/ajr.169.3.9275871","volume":"169","author":"T Franquet","year":"1997","unstructured":"Franquet T, Gimenez A, Monill JM, Diaz C, Geli C (1997) Primary Sjogren\u2019s syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 169(3):655\u2013658. https:\/\/doi.org\/10.2214\/ajr.169.3.9275871","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"4886_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jbspin.2016.05.019","volume":"84","author":"S Lechtman","year":"2017","unstructured":"Lechtman S, Debray MP, Crestani B, Bancal C, Hourseau M, Dossier A, Alexandra JF, Chauveheid MP, Papo T, Sacre K (2017) Cystic lung disease in Sj\u00f6gren\u2019s syndrome: an observational study. Joint Bone Spine 84(3):317\u2013321. https:\/\/doi.org\/10.1016\/j.jbspin.2016.05.019","journal-title":"Joint Bone Spine"},{"issue":"5","key":"4886_CR40","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1440-1843.2010.01772.x","volume":"15","author":"S Rajagopala","year":"2010","unstructured":"Rajagopala S, Singh N, Gupta K, Gupta D (2010) Pulmonary amyloidosis in Sjogren\u2019s syndrome: a case report and systematic review of the literature. Respirology 15(5):860\u2013866. https:\/\/doi.org\/10.1111\/j.1440-1843.2010.01772.x","journal-title":"Respirology"},{"issue":"4","key":"4886_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000214841","volume":"78","author":"JH Shi","year":"2009","unstructured":"Shi JH, Liu HR, Xu WB et al (2009) Pulmonary manifestations of Sjogren\u2019s syndrome. Respiration 78(4):377\u2013386. https:\/\/doi.org\/10.1159\/000214841","journal-title":"Respiration"},{"issue":"4","key":"4886_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/RTI.0b013e3181c1acec","volume":"24","author":"DA Lynch","year":"2009","unstructured":"Lynch DA (2009) Lung disease related to collagen vascular disease. J Thorac Imaging 24(4):299\u2013309. https:\/\/doi.org\/10.1097\/RTI.0b013e3181c1acec","journal-title":"J Thorac Imaging"},{"issue":"6","key":"4886_CR43","first-page":"1077","volume":"34","author":"MH Chen","year":"2016","unstructured":"Chen MH, Chen CK, Chou HP, Tsai CY, Chang DM (2016) Rituximab therapy in primary Sjogren\u2019s syndrome with interstitial lung disease: a retrospective cohort study. Clin Exp Rheumatol 34(6):1077\u20131084","journal-title":"Clin Exp Rheumatol"},{"issue":"140","key":"4886_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sjogren\u2019s syndrome. Eur Respir Rev 25(140):110\u2013123. https:\/\/doi.org\/10.1183\/16000617.0011-2016","journal-title":"Eur Respir Rev"},{"issue":"3","key":"4886_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bjh.13192","volume":"168","author":"G Nocturne","year":"2015","unstructured":"Nocturne G, Mariette X (2015) Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol 168(3):317\u2013327. https:\/\/doi.org\/10.1111\/bjh.13192","journal-title":"Br J Haematol"},{"issue":"20","key":"4886_CR46","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165(20):2337\u20132344. https:\/\/doi.org\/10.1001\/archinte.165.20.2337","journal-title":"Arch Intern Med"},{"issue":"5","key":"4886_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","volume":"88","author":"E Baimpa","year":"2009","unstructured":"Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM (2009) Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88(5):284\u2013293. https:\/\/doi.org\/10.1097\/MD.0b013e3181b76ab5","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"4886_CR48","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/art.39518","volume":"68","author":"G Nocturne","year":"2016","unstructured":"Nocturne G, Virone A, Ng WF et al (2016) Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 68(4):977\u2013985. https:\/\/doi.org\/10.1002\/art.39518","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4886_CR49","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1378\/chest.12-0547","volume":"143","author":"EM Kluka","year":"2013","unstructured":"Kluka EM, Bauer PR, Aubry MC, Ryu JH (2013) Enlarging lung nodules and cysts in a 53-year-old woman with primary Sjogren syndrome. Chest 143(1):258\u2013261. https:\/\/doi.org\/10.1378\/chest.12-0547","journal-title":"Chest"},{"issue":"4","key":"4886_CR50","first-page":"925","volume":"30","author":"K Kocijancic","year":"2006","unstructured":"Kocijancic K, Kocijancic I (2006) Primary Sjogren\u2019s syndrome associated with non-Hodgkin\u2019s lymphoma of salivary gland and cystic lung disease. Coll Antropol 30(4):925\u2013927","journal-title":"Coll Antropol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04886-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04886-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04886-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T00:49:01Z","timestamp":1608338941000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04886-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4886"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04886-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"30 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Written informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}